A detailed history of Geode Capital Management, LLC transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 1,696,354 shares of SRPT stock, worth $207 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
1,696,354
Previous 1,652,048 2.68%
Holding current value
$207 Million
Previous $261 Million 18.83%
% of portfolio
0.02%
Previous 0.02%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$124.33 - $156.75 $5.51 Million - $6.94 Million
44,306 Added 2.68%
1,696,354 $212 Million
Q2 2024

Aug 09, 2024

BUY
$113.33 - $163.85 $14.9 Million - $21.6 Million
131,678 Added 8.66%
1,652,048 $261 Million
Q1 2024

May 13, 2024

BUY
$93.7 - $141.53 $4.76 Million - $7.19 Million
50,833 Added 3.46%
1,520,370 $197 Million
Q4 2023

Feb 13, 2024

BUY
$67.31 - $124.76 $4.09 Million - $7.58 Million
60,762 Added 4.31%
1,469,537 $142 Million
Q3 2023

Nov 13, 2023

BUY
$102.5 - $123.59 $2.12 Million - $2.56 Million
20,692 Added 1.49%
1,408,775 $171 Million
Q2 2023

Aug 11, 2023

BUY
$106.4 - $157.19 $13.4 Million - $19.8 Million
126,112 Added 9.99%
1,388,083 $159 Million
Q1 2023

May 15, 2023

BUY
$117.53 - $155.99 $5.08 Million - $6.74 Million
43,239 Added 3.55%
1,261,971 $174 Million
Q4 2022

Feb 13, 2023

BUY
$100.86 - $132.13 $6.5 Million - $8.51 Million
64,434 Added 5.58%
1,218,732 $158 Million
Q3 2022

Nov 14, 2022

BUY
$75.71 - $119.24 $1.13 Million - $1.78 Million
14,915 Added 1.31%
1,154,298 $128 Million
Q2 2022

Aug 12, 2022

SELL
$62.69 - $88.44 $582,202 - $821,342
-9,287 Reduced 0.81%
1,139,383 $85.4 Million
Q1 2022

May 13, 2022

BUY
$63.15 - $90.42 $1.05 Million - $1.5 Million
16,614 Added 1.47%
1,148,670 $89.7 Million
Q4 2021

Feb 11, 2022

BUY
$77.28 - $99.42 $11.4 Million - $14.6 Million
147,103 Added 14.94%
1,132,056 $102 Million
Q3 2021

Nov 12, 2021

BUY
$65.97 - $92.48 $43,870 - $61,499
665 Added 0.07%
984,953 $91.1 Million
Q2 2021

Aug 13, 2021

BUY
$69.38 - $86.75 $1.01 Million - $1.26 Million
14,525 Added 1.5%
984,288 $76.5 Million
Q1 2021

May 12, 2021

BUY
$72.25 - $168.95 $2.23 Million - $5.22 Million
30,880 Added 3.29%
969,763 $72.2 Million
Q4 2020

Feb 12, 2021

BUY
$125.56 - $178.74 $6.57 Million - $9.35 Million
52,302 Added 5.9%
938,883 $160 Million
Q3 2020

Nov 13, 2020

SELL
$127.12 - $172.34 $832,000 - $1.13 Million
-6,545 Reduced 0.73%
886,581 $124 Million
Q2 2020

Aug 13, 2020

BUY
$93.0 - $171.7 $3.94 Million - $7.27 Million
42,320 Added 4.97%
893,126 $143 Million
Q1 2020

May 14, 2020

BUY
$82.38 - $131.64 $5.27 Million - $8.42 Million
63,996 Added 8.13%
850,806 $83.2 Million
Q4 2019

Feb 13, 2020

BUY
$76.53 - $135.58 $2.19 Million - $3.89 Million
28,680 Added 3.78%
786,810 $101 Million
Q3 2019

Nov 12, 2019

BUY
$72.81 - $156.91 $1.16 Million - $2.49 Million
15,879 Added 2.14%
758,130 $57.1 Million
Q2 2019

Aug 14, 2019

BUY
$112.21 - $151.95 $5.56 Million - $7.53 Million
49,567 Added 7.16%
742,251 $113 Million
Q1 2019

May 14, 2019

BUY
$106.67 - $151.68 $3.62 Million - $5.15 Million
33,931 Added 5.15%
692,684 $82.6 Million
Q4 2018

Feb 13, 2019

BUY
$97.32 - $148.76 $6.58 Million - $10.1 Million
67,601 Added 11.44%
658,753 $71.9 Million
Q3 2018

Nov 13, 2018

BUY
$115.31 - $161.51 $1.57 Million - $2.19 Million
13,587 Added 2.35%
591,152 $95.5 Million
Q2 2018

Aug 14, 2018

SELL
$71.74 - $153.69 $131,068 - $280,791
-1,827 Reduced 0.32%
577,565 $76.3 Million
Q1 2018

May 15, 2018

BUY
$54.02 - $82.27 $1.08 Million - $1.64 Million
19,936 Added 3.56%
579,392 $42.9 Million
Q4 2017

Feb 13, 2018

BUY
$47.64 - $56.75 $649,380 - $773,559
13,631 Added 2.5%
559,456 $31.1 Million
Q3 2017

Nov 14, 2017

BUY
$35.73 - $47.15 $3.56 Million - $4.69 Million
99,556 Added 22.31%
545,825 $24.8 Million
Q2 2017

Aug 14, 2017

BUY
N/A
446,269
446,269 $15 Million

Others Institutions Holding SRPT

About Sarepta Therapeutics, Inc.


  • Ticker SRPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,567,904
  • Market Cap $10.7B
  • Description
  • Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...
More about SRPT
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.